To access this element change to forms mode OFF
Grant Award View - GA166524
The NLRP3 inflammasome as a potential biomarker and therapeutic target...
GA ID:
GA166524
Agency:
Department of Health and Aged Care
Approval Date:
27-Apr-2021
Publish Date:
25-May-2021
Category:
Health and Medical Research
Grant Term:
1-Jun-2021 to 31-May-2024
Value (AUD):
$645,763.70
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 1.1 Health Policy Research and Analysis
Grant Program:
2020_MRFF_EPCDR_Silicosis Research
Grant Activity:
The NLRP3 inflammasome as a potential biomarker and therapeutic target for silicosis
Purpose:
Inhalation of silica particles by artificial stone workers can lead to the development of silicosis disease and there are currently no available treatments. This project will identify new indications of disease risk, as well as anti-inflammatory drugs that can improve silicosis disease.
GO ID:
GO Title:
MRFF – EPCDR Initiative - 2020 Silicosis Research Grant Opportunity
Internal Reference ID:
MRF2006197
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA